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rats bearing Yoshida sarcoma reached its peak 24 h after the administration of 67Ga and gradually
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contact time of 24 h. This indicated a significant delay in excretion in comparison with that of
normal skin fibroblasts. This delay in the excretion of 67Ga may be an important factor in the
tumor accumulation of 67Ga.
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Abstract. Using in vivo -and in vitro experimental models, the up-
take and excretion of 67Ga-citrate in tumor cells and normal cells were
studied. The time-lapse accumulation of 67Ga in the tumor of rats bear-
ing Yoshida sarcoma reached its peak 24 h after the administration of
67Ga and gradually decreased thereafter. However, the excretion of
67Ga from the tumor was less than that from normal lung. For culture
cells in vitro, the uptake of 67Ga increased with lapse of contact time be-
tween 67Ga and the cells, but there was no distinct difference between
the results for tumor cells and normal skin fibroblasts. The excretion of
67Ga from the cells tended to decrease with prolongation of the contact
time, the excretion from tumor cell being only about 10% after a contact
time of 24 h. This indicated a significant delay in excretion in compari-
son with that of normal skin fibroblasts. This delay in the excretion of
67Ga may be an important factor in the tumor accumulation of 67Ga.
Key words: 67Ga uptake and excretion, malignant cells
Ever since 1969 when it was reported by Edwards and Hayes that 67Ga_
citrate accumulated to a high degree in Hodgkins's disease (1), the tumor ac-
cumulation of 67Ga has been studied from fundamental and clinical aspects by
many investigators. The usefulness of 67Ga as a tumor scanning agent was then
established (2-5). Subsequently, the tumor accumulation of other radioisotopes
such as 111In013 (6), 169Yb (7), 570o-Bleomycin (8), 99mTc-Bleomycin (9) and
201Tl (10, 11) was reported. These radioisotopes have also been applied to clini-
cal practice. However, 67Ga and these other radioisotopes all accumulate in
inflammatory foci; (12) moreover, tumor specificity, at lack of it, is still a prob-
lem. Hence the search for a superior radioisotope continues.
Tumor accumulation of tumor scanning agents including 67Ga has been
studied by various methods but no definitive conclusions have yet been reached
(13) . An understanding of the mechanism of tumor accumulation is essential to
formulating diagnosis. It is also important in attempting to a new radioisotope.
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In this paper, the author studied the difference in excretion of 67Ga from tumor
cells and normal cells using in vivo and in vitro models. The results are presented
here and their significance is discussed.
MATERIALS AND METHODS
Radioisotope. 67Ga-citrate was obtained from the Daiichi Radioisotope Labo-
ratory. On the assay date, 1 mCi of carrier-free 67Ga was dissolved in physiolog-
ical saline containing 1.8 mg sodium citrate, then diluted to the appropriate con-
centration.
Animal experiments. Using male Donryu rats (weight 128-179 g), 0.2 ml of
Yoshida sarcoma ascites (cell number: cir. 4 x 107cells) was transplanted sub-
cutaneously into the left femur. Experiments were conducted 5-7 days after this
transplantation, during which time the tumor had grown to 1.5-2 cm in diameter.
67Ga-citrate in a dose of 10 pCi per animal was injected intravenously from a tail
vein. Six-seven cancer-bearing rats from each group were sacrificed at intervals
of 3, 24, 48 and 72 after the injection, and the 67Ga-acumulation in various organs
was measured. The measured values were expressed as % dose/l % body weight
for each organ so as to obviate differences due to body weight.
Culture cells and conditions. The cells used for the experiment consisted of
HeLaS3 cells, ASH cells (14) derived from human ovary embryonic cancer,
normal skin fibroblast (normal S. F.) and Yoshida sarcoma cells. The doubling
time for each of the 4 kinds of cells was HelaS3: cir. 19h, ASH: cir. l7h, normal
S. F.: cir. 4lh and Yoshida sarcoma cells: cir. l7h. HeLaS3, ASH, and normal
S. F. cells all proliferated by adhering to the walls of the culture vessel. A CO2
incubator was used to incubate these sells. Yoshida sarcoma cells were cells cul-
tured from Yoshida sarcoma ascites in rats. These cells proliferate while sus-
pended in the medium. For their incubation, the temperature was maintained at
37°C and the culturers were shaken at fixed intervals. Eagle's MEM medium
containing 10% fetal calf serum was used in all cultures and the experiments
were undertaken at the logarithmic growth phase,
Experiments using a monolayer culture method. Cells were planted in 2ml
medium in a plastic Petri dish 35mm in diameter then incubated for 24-48h at
37°C (Fig. 1). Next carrier-free 67Ga-citrate usually in the concentration of l,uci/
ml-medium was added. Further incubation for 0.5, 3,6, 12 or 24 h was performed
then, while the Petri dish were cooling in ice, each culture was washed 3 times
with 2 m cold PBS. To standardize the cell count, the administration time of 67Ga
was made to coincide with this washing time. To measure the ~ptake of 67Ga,
1 ml of 0.2% trypsin solution was added, incubation allowed for 20 min at 37°C,
then the cells were transferred from the Petri dish to a test tube. To eliminate
the effect of 67Ga attached to the Petri dish, the tube was washed with 7 ml cold
PBS and centrifuged at 4°C and 1,000 r.p.m. for 10 min. This was done twice,
then the test tube was placed in a well type scintillation counter (window: 93 ±
25keV) and the activity of 67Ga in the cells was measured. To measure the ex-
cretion of 67Ga, each culture was washed with cold PBS, fresh medium was
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added, and further incubation allowed. The activity of 67Ga remaining in the
cell was measured during the next 12 h. To prevent resorption of 67Ga either
adhered to the vessel or previously excreted, the medium was exchanged for a
fresh medium at 1, 2, 4, 6, 8 and 10 h.
Experiments using a suspension culture method. With a plastic test tube 12 mm
in diameter, cells planted in 2 ml medium were subjected to suspension culture
and 67Ga was added as for the monolayer culture (Fig. 2). Thereafter, each was
incubated for 0.5, 1, 3, 6, 12 and 24 h, centrifuged with 7ml of cold PBS at 4°C,
1,000 r.p.m. for 10 min, and washed 3 times. The uptake of 67Ga in the cell was
then measured. To measure excretion, each culture was washed with PBS and
fresh medium was added. 67Ga remaining in the cell during the next 12 h was
measured without any exchange of medium.
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Fig. 1. Schema for experimental methods of Ga-67 uptake and excretion in HeLaS3, ASH
and normal skin fibroblasts.
Fig. 2. Schema for experimental methods of Ga-67 uptake and excretion in Yoshida sar-
coma.
RESULTS
Time-lapse changes of 76Ga distribution in the tumor and organs of Yoshida
sarcoma-bearing rats. As shown in Fig. 3, 67Ga activity in blood and lung de-
creased with lapse of time, but rose to a peak for the tumor node and the liver,
after which it tended to gradually decrease. The accumulation of 67Ga was less
in muscle than in the other tissues, being maintained at a fixed level from 3 h
to 72 h after administration.
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Fig. 3. Time-lapse changes of Ga-67 distribution in the tumor and organs of Yoshida sar-
coma-bearing rats. Each point is expressed as mean ± standard deviation for 6-7 rats.
The level of 67Ga in the tumor node decreased so that, at 72 h, it was 60%
of that at 24 h after the administration of 67Ga. At the same time, in the liver it
was about 80 %, and in the lung, about 30 %, indicating that the excretion of
67Ga from the tumor node was faster than from the liver, but a marked delay
was recognized as compared with the normal lung.
Effect of cell density and 67Ga concentration on the 67Ga-uptake in culture cells.
Fig. 4 shows the relation between cell counts and the uptake of 67Ga when
incubation was carried out for 24 h in medium containing l,uCi/ml-medium of
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Fig. 4. Gallium-67 uptake by varying numbers of HeLaS3, normal skin fibroblasts and
Yoshida sarcoma. Cells were incubated with I ,uCi/ml Ga-67 for 24 h at 37°C.
67Ga. In the cultures of HeLaS3 and Yoshida sarcoma cells, the uptake of 67Ga
was measured by varying the cell counts up to 2 X 106cells per Petri dish or test
tube. In the culture of normal S.F., the stationary phase was reached at cir.
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4 X 105 cells per Petri dish, so uptake of 67Ga was measured by varying the cell
counts up to 4 X 105 cells per Petri dish. The uptake of 67Ga increased linearly
with increase in cell numbers in every case as shown by the solid line (Fig. 4).
However, with HeLaS and normal S. F., the solid line does not pass through the
original point. When the cell density was less, the uptake of 67Ga/106 cells
tended to incrase as shown by the dotted line. With Yoshida sarcoma cells, a
straight line passing through the original point was obtained, and irrespective
of the cell density the uptake of 67Ga/106 cells became almost constant. Cell
counts at the time 67Ga-uptake was measured were: HeLaS3; cir. 50-100 X 104
cells/dish; normal S. F. : cir. 3-30 X 104cells/dish; Yoshida sarcoma: cir.50-
100 X 104/test tube. The cell counts of ASH were the same as those of HeLaS3.
The relationship between 67Ga concentration and 67Ga-uptake in HaLaS3
and normal S. F. cells is shown in Fig. 5. The readings were taken after incuba-
tion for 24 h following the addition of 67Ga. The cell counts were HeLaS3:
48.2 X 104/dish, normal S.F.: 3.4 X 104/dish. In both instances, the uptake of
67Ga increased in proportion to the concentration of 67Ga from 0.25 to 5 p.
Cijml-medium. There was no saturation point for 67Ga-uptake.
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Fig. 5. Effect of various Gallium concentrations on Ga-67 uptake by HeLaS3 and normal
skin fibroblasts. Each point is the mean of two experiments.
Fig. 6. Time course of Ga-67 uptake by HeLaS3 and normal skin fibroblasts. Cells were
incubated with I pCi/ml Ga-67 for varying intervals at 37°C. Each point is expressed as
%dose/106 cells and is the mean of two experiments.
Time-lapse changes/or 67Ga-uptake by culture cells. The uptake of 67Ga by
HeLaS3 and normal S. F. with lapse of time is shown in Fig. 6. The abscissa
indicates incubation time (contact time) after the addition of 67Ga to the medium.
The ordinate indicates the amount of the uptake represented in % of 67Ga activ-
ity per 106cells. In both cases, the uptake increased rapidly immedeately after
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the addition of 67Ga. Between 3 and 24 h of contact time, the increase was
linear. The amount of 67Ga uptake/106cells was greater with normal S.F.
A comparison of the 67Ca-uptake at 24 h of contact time by HeLaS3 and
normal S.F. cells is shown in Table 1. The uptake/106 cells was 0.83 ± 0.30 %
with HeLaS3 and 3.55 ± 0.87 % with normal S.F. ; that is the uptake for normal
S.F. was about"4.3 times greater than that for HeLaS3. However, when the cells
in each culture were peeled with trypsin solution and the cell diameters measured
by a micrometer, normal S.F. had the diameter cir. 1.6 times larger than that of
HeLaS3. Consequently, the 67Ga-uptake per unit cell volume would be about
the same in both cell types.
TAILE 1. COMPARISON OF GA-67 UPTAKE BY HELAS3 AND NORMAL
SJ<;.IN FIBROBLASTS
HeLaS3
Normal skin fibroblasts
67Ga-uptakea
(% dose/106 cells)
O. 83±0. 30
3. 55±0. 87
Diameter of cellb
(,tt)
16.75± 3.38
27.25±I1.13
a Cells were incubated with I ,uCi/ml Ga-67 for 24 h, at 37°C. The results are expressed
as mean ± standard deviation for 7 experiments (HeLaS3l and 5 experiments (normal skin
fibroblast).
b The results are expressed as mean ± standard deviation for 50 cells.
Fig. 7 shows the uptake of 67Ga with lapse of time by Yoshida sarcoma cells.
The change in 67Ga-uptake was not marked between 30 min and 3 h of the con-
tact time, but as the contact time increased from 3 to 24 h, the uptake increased
linearly; that is, it was biphasisc. Adsorption to the test-tube used (30 cpm) was
negligible. Moreover, when Yoshida sarcoma was allowed to take up 67Ga in
the same manner as HeLaS3 and normal S.F. and incubated in 1m1 of 0.2 %
trypsin solution for 20 min, about 50 % 67Ga was liberated in 30 min of contact
time. In the period of 3-24 h, however, only 6-26% of 67Ga was liberated, and
as shown by the dotted line, from 30 min to 24 h 67Ga-uptake increased in approx-
imately a straight line.
Time-lapse excretion of 67Gafrom culture cells. Results of the study on 67Ga
excretion with lapse of time in HeLaS3 and normal S.F. are shown in Fig. 8.
Taking 67Ga-uptake by the cells as 100 %, the percentage of 67Ga remaining in
the cells during the period 2 to 12 h after the exchange of the medium was
measured. The contact time of 67Ga and the cell is in parenthesis in the figure.
Aft.er a contact time of 24 h, HeLaS3 showed a higher remnant percentage sug-
gesting a delay in excretion. Moreover, with a contact time between 0.5 hand
24 h, the remnant percentage at 0.5 h was clearly less, indicating that the ex-
cretion of 67Ga from the cell is related to the contact time.
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Fig. 7. Time course of Ga-67 uptake by Yoshida sarcoma. Experimental conditions were
as in Fig. 6. Each point is expressed as cpm/I06 cells.
Fig. 8. Time-Iaese excretion of Ga-67 from HeLaS3 and normal skin fibroblasts. Num-
bers in parenthesis indicate the contact time of Ga-67 and cells.
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Fig. 9. Effect of contact time on 67Ga-excretion from HeLaS3 and normal skin fibroblasts.
Each point is the mean of two experiments.
Fig. 10. Effect of various Gallium concentrations on excretion of Ga-67 from HeLaS3
and normal skin fibroblasts. Each point is the mean of two experiments.
Effects of contact time and concentration of 67Ga on 67Ga-excretion from the cell.
Fig. 9 shows the results of the study on the relation between contact time and the
remnant percentage of 67Ga 12 h later. Both cell groups showed and increase in
the remnant percentage as the contact time increased. This became constant at a
contact time of 12 to 24 h. In addition beyond a contact time of 6 h, the rem-
nant percentage between the two showed a difference, namely, HeLaS3 showed
less excretion than normal S. F.
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Fig. 10 shows the results of a comparison between the intracellular remnant
percentage of 67Ga at a contact time of 24 h in the cases where the 67Ga concent-
ration had been changed from 0.25 to 5,uCijml-medium. In both HeLaS3 and
normal S.F., this change in the 67Ga concentration produced no marked effect on
the excretion.
Comparison of 67Ga-excretion in various culture cells. Taking the 67Ga-uptake
at 24 h of the contact time as 100 %, the intracellular remnant percentage of
67Ga 12 h after the medium exchange was compared for various cells (Table 2).
In one experiment 2-5 Petri dishes or test tubes were used and the results of 4-6
experiments were summarized for each cell group. The 67Ga-excretion was
89.0 ± 7.4 % in HeLaS3, 87.1 ± 9.7% in ASH, 63.9 ± 10.5% in normal S.F. and
in Yoshida sarcoma cells, although the experimental conditions were somewhat
different, 89.7 ± 6.1 %. In HeLaS3, ASH. and Yoshida sarcoma cells, all of
which are tumor cells, the intracellular remnant percentage was approximately
equal. When HeLaS3 and normal S.F. were compared statistically, the level of
significance was less than 1%, indicating a highly significant difference. More-
over, there was also a significant difference between ASH and normal S.F. as
the level of significance was less than 5%, indicating a delay in 67Ga-excretion
from tumor cells compared with normal S. F.
TABLE 2. COMPARISON 67GA-EXCRETION FROM HELAS3, ASH, NORMAL SKIN
FIBROBLASTS AND YOSHIDA SARCOMA
HeLaS3
AS H
Normal skin fibroblasts
Yoshida Sarcoma
Doubling
time (h)
19.2
17.4
40.8
17.2
Retentiona,
(%)
89.0 ± 7.4 (6)
87.1 ± 9.7 (4)
63. 9 ± 10. 5 (5)
89.7 ± 6. 1 (4)
P valuesb
(vs normal skin fibroblast)
< 0.01
< 0.05
a The results are expressed as mean ± standard deviation. The numbers in parentheses
indicate the number of experiments.
b P values were obtained based on paired difference.
DISCUSSION
From the fact that 67Ga accumulates strongly not only in tumor tissues but
also in inflammatory foci, Ito et at. (2) consider that neovascularity and hyper-
permeability are important as accumulation mechanisms. They consider that
67Ga first combines with serum protein (most probably albumin), then ap-
proaches the tumor through various vascular routes. These routes increase in
size and number secondary to tumor or inflammation and increase in permeabil-
ity. The resultant overflow from the blood vessels enables the 67Ga to enter
8
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tumor cells as the ion, which then combines with-the cytoplasm where it remains.
Although many other factors are involved, it is important to clarify why 67Ga
remains in a tumor or inflammatory focus for a long period of time. Information
on delay in the excretion of 67Ga in relation to its accumulation would be helpful,
but reports on this point are rare. Paterson et al. (15) reported that, in animal
experiments, 67Ga excretion from lactating mammary glands was about the same
as 45Ca, whereas 67Ga excreted from tumor was far less. Moreover, the 67Ga
remained for a long period of time.
In tumor cells, it was reported (2, 5) that 67Ga occurred abundantly in the
soluble fraction, but since then, Swartzendruber et ai. localized its accumulation
to 1ysosomes (16).
Therefore, the author studied in vivo time changes in the radioactivity of 67Ga
in Yoshida sarcoma, liver, lung, muscle and blood specimens. The uptake and
excretion of 67Ga were studied in cell cultures to exclude vascular factors.
The in vivo time-lapse accumulation of 67Ga in Yoshida sarcoma node and
liver reached a peak 24 h after administration, then gradually decreased. In
both tissues, the 67Ga-accumulation increased despite continued decrease in the
blood level of 67Ga, suggesting an active take up of 67Ga. In addition, even
though the radioactivity of the tumor and the liver decreased gradually 24 h after
the administration, it was distinctly higher than for other organs. Decreased 67Ga
accumulation in the tumor node may reflect rapid growth and degeneration of
Yoshida sarcoma during the experimental period. Interstitial fluid in the tumor
tissue is more abundant than in normal tissue (17) and excretion of 67Ga from
this interstitial fluid exceeds that of normal tissue, hence the excretion is not
necessarily from tumor cells only. The excretion of 67Ga from Yoshida sarcoma
cells in vitro gave an intracellular remnant percentage of approximately 90 % at
24 h of contact time, which was considerably less than that in vivo.
Concerning the uptake of 67Ga in vitro, Glickson et ai. (18, 19) reported a
comparative study of 67Ga in various media such as 0.9 % NaCl solution and
Glucose-Lock's solution using L 1210 cells. They also studies the effects of in-
cubation temperature and pH. Awano and Matsuzawa (20) reported that malig-
nant culture cells undergoing vigorous proliferation ingested a greater amount of
67Ga than malignant culture cells not proliferating. The present experiment
was conducted with Eagle's MEM medium and at the logarithmic growth phase
to allow observations over a long period of time under conditions in which the
cells show the most activity.
The time-lapse uptake of 67Ga in the culture cells increased along with in-
crease in the contact time as shown in Figs. 7, 8. The change in uptake for
Yoshida sarcoma cells without trypsin treatment was less during the first 3 h of
contact time, but between 3 hand 24 h of contact time it increased linearly,
9
Muranaka: Accumulation of radioisotopes with tumor affinity.
Produced by The Berkeley Electronic Press, 1978
416 A. MURANAKA
showing a biphasic tendency. The fact that about 50% of 67Ga was liberated by
trypsin treatment after 30 min of contact with the Yoshida sarcoma cells suggests
that 67Ga attaches to the cell membrane in the initial stage after 67Ga addition to
the medium and is gradually taken up into the cell thereafter. Tsan et at. (21)
reported that, in their experiments with human polymorphonuclear leukocytes,
the uptake of 67Ga was maximal at a contact time of 30 min. Trypsin treatment
resulted in about 50% of 67Ga being liberated, so they considered that 67Ga
combines with cell membrane. However, the present experimental results in-
dicate that a longer contact time is necessary for the evaluation of 67Ga-uptake.
Normal skin fibroblasts at the longarithmic growth phase showed about a
4.3 times greater uptake of 67Ga than HeLaS3 cells. However, normal skin
fibroblasts have a greater cell diameter so the uptake per unit volume in the
both cases was approximately the same. Namely, the in vitro experiments which
excluded vascular factors showed that there was no distinct difference in the
uptake of 67Ga between tumor cells and normal cells.
The excretion of 67Ga from culture cells tended to decrease as the contact
time increased, becoming a constant at 12 h. There was a distinct delay in ex-
cretion from HeLaS3 after 6 h of contact time in comparison with normal skin
fibroblasts. These results suggest that the shorter the contact time is, the greater
is the proportion of 67Ga liberated. The reason for this is that a greater amount
of 67Ga combines to cell membrane, and uncombined 67Ga to cell components,
so that with longer contact time, the amount of 67Ga combined to cell components
increases and consequently, excretion decreases. Difference in the combination
of 67Ga to the intracellular components of tumor and normal cells may account
for the delayed excretion from tumor cells.
Even when the concentration of 67Ga was altered from 0.25pCijml-medium
to 5/lCijml-medium, the uptake of 67Ga was practically constant and excretion
of 67Ga was unaffected. One report (22) discribes increased excretion from
normal tissues after the administration of stable Ga, hence further studies are
required.
The results indicate that the delay in excretion from tumor cells plays an
important role in tumor accumulation of 67Ga.
Acknowledgment. The author wishes to express profound thanks to Prof. Michio Yama-
moto, Department of Radiology, Okayama University Medical School, for guidance. Ac-
knowledgment is also due to Ass. Prof. Masayoshi Nanba and Mr. Koji Nishitani of Dept. of
Experimental Pathology, Kawasaki Medical School, for guidance and advice on the cell cul-
ture methods.
REFERENCES
1. Edwards, C. L. and Hayes, R. L.: Tumor scanning with 67Ga citrate. J. Nucl. Med. 10,
103-105, 1969. '
10
Acta Medica Okayama, Vol. 32 [1978], Iss. 6, Art. 5
http://escholarship.lib.okayama-u.ac.jp/amo/vol32/iss6/5
Uptake and Excretion of 67Ga 417
2. Ito, Y., Okuyama, S., Sato, K., Takahashi, K., Sato, T. and Kanno, 1.: 67Ga tumor scan-
ning and its mechanisms studied in rabbits. Radiology 100, 357-362, 1971.
3. Ito, Y., Okuyama, S., Awano, T., Sato, T. and Kanno, 1.: Diagnostic evaluation of 67Ga
scanning of lung cancer and other disease. Radiology 101, 355-362, 1971.
4. Langhammer, H., Glaubitt, G., Grebe, S. F., Hampe, J. F., Haubold,o., Hor, G., Kaul,
A., Koeppe, P., Koppenhagen, J., Roedler, H. D. and Schoot, J. B.: 67Ga for tumor scan-
ning. j. Nucl. Med. 13, 25-30, 1972.
5. Orii, H.: Tumor scanning with gallium (67Ga) and its mechanism studied in rats. Strahlen-
therapie 144, 192-200, 1972.
6. Hunter, W. W. and Riccobono, X. J.: Clinical evaluation of lllIn for localization of re-
cognized neoplastic disease. j. Nucl. Med. 11, 328-329, 1970.
7. Hisada, K., Tonami, N., Hiraki, T. and Ando, A.: Tumor scanning with 169Yb-citrate. j.
Nucl. Med. 14, 772-773, 1973.
8. Nouel, J-P., Renault, H., Robert, J., Jeanne, C. and Wicent, L.: La bleomycine marquee
au Co 57. Nouv. Presse Med. I, 95-98, 1972.
9. Mori, T. and Hamamoto, K.: Fundamental and clinical studies on 99mTc labeled Bleo-
mycin, a new tumor scanning agent. jpn. j. Nucl. Med. 9, 353, 1972 (in Japanese).
10. Salvatore, M., Carrati, L., Bazzicalupo, L. and Mansi, L.: The use of Tl-201 thallium
chloride as a positive tumor indicator. Eur. j. Nuc!. Med. 1, 95, 1976.
11. Ito, Y., Muranaka, A., Harada, T., Matsudo, A., Yokobayashi, T. and Terashima, H.:
Experimental study on tumor affinity of 201Tl-chloride. Eur. j. Nucl. Med. 3, 81-86, 1978.
12. Ito, Y., Okuyama, S., Takahashi, K., Sato, T., Nakamura, K., Ichikawa, T. and Muranaka,
A.: Role of inflammation in tumorous accretion of radiopharmaceuticals: Experimental
studies with 67Ga, 169Yb, lllIn, 99mTc-Pertechnetate, 99mTc-Bleomycin, 5lCo-Bleomycin and
198Au-Colloid. Radioisotopes 24, 410-415, 1975.
13. Hayes, R. L.: Factors affecting uptake of radioacsive agents by tumor and other tissues.
In TU'Tlor Localization with Radioactive Agents. International Atomic Energy Agency,
Vienna, pp.29-45, 1976.
14. Kimoto, T., Ueki, A. and Nishitani, K.: A human malignant cell line established from
ascites of patient with embryonal carcinoma of ovarium. Acta Pathol. jpn. 25, 89-98,
1975.
15. Paterson, A. H. G., Yoxall, A., Smith, I., Taylor, D. M. and McCready, V. R.: The con-
centration of 67Ga and 45Ga in the lactating mammary gland and its relevance to the
tumor uptake of 67Ga citrate. Cancer Res. 36, 452-457, 1976.
16. Swartzendruber, D. C., Nelson, B. and Hayes, R. L.: Gallium-67 localization in lysosomal-
like granules of leukemic and nonleukemic murine tissues. j. Nat!. Cancer Inst. 46, 941-
952, 1971.
17. Gullino, P. M.: The internal milieu of tumors. Prog. Exp. Tumor Res. 8, 1-25, 1966.
18. Glickson, J. D., Ryel, R. B., Bordenca, M. M., Kim, K. H. and Gams, R. A.: In vitro bind-
ing of 67Ga to Ll210 cells. Cancer Res. 33, 2706-2713, 1973.
19. Glickson, J. D., Webb, J. and Gams, R. A.: Effects of buffers and pH on in vitro binding
of 67Ga by Ll210 leukemic cells. Cancer Res. 34, 2957-2960, 1974.
20. Awano, T. and Matsuzawa, T.: Accumulation and biological effects of gallium in malig-
nant cell lines in vitro. lPn. j. Nucl. Med. 14, 73-81, 1977 (in Japanese).
21. Tsan, M. F., Chen, W. Y., Scheffel, U. and Wagner, H. N.: Studies on gallium accumula-
tion in inflammatory lesions: 1. Gallium uptake by human polymorphonuclear leuko-
cytes. j. Nucl. Med. 19, 36-43, 1978.
22. Hayes, R. L.: 67Gallium as a tumor scanning agent. In ORA U lID, 1969 Research Report,
Medical Division of Oak Ridge Associated Universitties, Oak Ridge, pp.8l-85, 1969.
11
Muranaka: Accumulation of radioisotopes with tumor affinity.
Produced by The Berkeley Electronic Press, 1978
